Although PMX triggered AKT activation (pAKT) in a dose-dependent fashion among two of three AD cell lines, PMX had the opposite effect among two of three SCC cell lines, with only Ludlu1 displaying a transient pAKT increase (Figure 4A and Figure S6). The gene discussed is AKT1; the disease is Alzheimer disease.